✦ LIBER ✦

444 A phase I/II study of oblimersen sodium in combination with oxaliplatin, 5-FU and leucovorin (FOLFOX4 regimen) in patients with advanced colorectal cancer

✍ Scribed by C. Mita; M. Goldston; J. Kuhn; M.J. Egorin; M. Beeram; A. Patnaik; M.M. Mita; J.S. DeBono; E.K. Rowinsky; A.W. Tolcher

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Front-line Bevacizumab in combination wi

✍ Christos Emmanouilides; Georgia Sfakiotaki; Nikolaos Androulakis; Kostas Kalbaki 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 263 KB

An EORTC phase I study of Bortezomib in

✍ F. Caponigro; D. Lacombe; C. Twelves; J. Bauer; A.-S. Govaerts; S. Marréaud; A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Postoperative chemoradiotherapy in gastr

✍ Xin Wang; Yongsheng Wang; Meng Qiu; Qiu Li; Zhi-ping Li; Bing He; Feng Xu; Ya-li 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 177 KB

A phase II study of FOLFIRI-3 (double in

✍ Louvet, C; de Gramont, A; Mabro, M; Artru, P; André, T; Flesch, M; Maindrault-Go 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Phase I/II study of irinotecan, 5-fluoro

✍ Ayumu Goto; Yasuhide Yamada; Ayumu Hosokawa; Takashi Ura; Tatsuhiro Arai; Tetsuy 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

Phase II study of FOLFIRI regimen in pat

✍ Han Ying Bao; Wei Jia Fang; Xiao Chen Zhang; Gen Ming Shi; Sui Huang; Lan Fang Y 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 269 KB